Go to Page # Page of 17

FDA and Medical Device Preemption

 Cydney Boler
Description: Navigating the FDA, and understanding Medical Device Preemption. Any device that diagnosis, cure, mitigation, treatment or prevention of disease or a condition that affects the structure or function of the body. Does not achieve intended use through chemical action is not metabolized. The shelf life of an average medical device is 18 months, quick rate of change in the industry.
Views: 2481
Domain: Medical
Category: Equipment
Navigating the FDA, and understanding Medical Device Preemption
Presented by Cydney Boler Special Counsel Foulston Siefkin cboler@foulston.com 913-253-2158 March 9, 2010

A bit of Legalese upfront: The Disclaimer
� The content of this presentation is my own and does not necessarily reflect the views and/or policies of Foulston Siefkin LLP. Foulston Siefkin LLP will not be bound by any ... See more

Recent Presentations

FDA Approach to the Opioids Crisis

Opioid Crisis is not one crisis, but multiple challenges to prescribers, patients & healthcare system. FDA is working in a prioritized way in multiple areas to confront opioid over

18 April, 2019
Ralph F. Hall
17 April, 2019

Investment Trends in Healthcare

Macroeconomic drivers are leading to an unprecedented healthcare industry change. Healthcare is one of the most impacted industry by technology breakthrough.

Danilo Mazzara
16 April, 2019